CD79A and COVID-19: Recently, a study, which examined the patterns of humoral and cellular responses to SARS-CoV-2 for 6 months during the COVID-19 pandemic, reported that subjects who had IgA antibodies only never succumbed to COVID-19, as opposed to subjects with both IgG antibodies and T cells who contracted the disease.32